webinar register page

Psychedelic Medicine: Research, Regulations, & the Future of Psilocybin- and MDMA-Assisted Therapy
As research continues to demonstrate that psychedelic drugs can have potential benefits in a therapeutic setting, attention has now turned towards the training of therapists who will administer such therapies once they are fully approved by the FDA. Currently, the University of Baltimore is exploring a possible training partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS). This symposium will feature a series of guest lectures on current research and approaches to therapy from experts in the field of psychedelic medicine.

Feb 25, 2021 07:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: UB OTS.